Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001797230 | SCV002038638 | uncertain significance | not provided | 2025-03-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001797230 | SCV003265994 | likely benign | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541304 | SCV003689841 | uncertain significance | Inborn genetic diseases | 2022-06-24 | criteria provided, single submitter | clinical testing | The c.4175A>G (p.K1392R) alteration is located in exon 27 (coding exon 27) of the PIEZO2 gene. This alteration results from a A to G substitution at nucleotide position 4175, causing the lysine (K) at amino acid position 1392 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV001797230 | SCV005193237 | uncertain significance | not provided | criteria provided, single submitter | not provided |